EUVIMEDEUVIMED entdecken
Crossref

CT Guided Microwave Ablation for Hepatocellular Carcinomas: Outcomes From a Tertiary Australian Centre

Andrew Whittering iD, Arani Halder

Journal of Medical Imaging and Radiation Oncology · 2026

DOI: 10.1111/1754-9485.70070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Imaging and Radiation Oncology, 2026. Verfasst von Andrew Whittering und 1 weiteren Autor:innen. Beteiligte Einrichtung: Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia. Hauptthemen laut MEDLINE: Liver Neoplasms, Carcinoma, Hepatocellular, Microwaves, Tomography, X-Ray Computed. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

CT guided microwave ablation (MWA) provides a suitable nonsurgical alternative for the treatment of hepatocellular carcinomas (HCC) in order to improve overall survival and local tumour progression. The purpose of this retrospective audit was to evaluate the overall efficacy of MWA and provide local data into the treatment's success, recurrence rates and overall survival.

Methods

A retrospective single centre audit of MWA for Hepatocellular Carcinomas (HCC) undertaken by interventional radiology at a large tertiary centre identified 90 eligible participants between January 2019 and 31st August 2024. Analysis among participants evaluated the overall technical success, procedural morbidity and mortality, and oncological outcomes including overall survival and local tumour progression through descriptive statistics.

Results

Of the 89 included participants (90 ablated HCCs), there was no reported immediate post‐procedure residual disease with a peri‐procedure morbidity of 5.6%, with all reported procedural complications minor. Median recurrence‐free survival was 26.5 months (IQR 8.25–39.75 months) with a median time to local tumour progression of 12 months (IQR 8.5–48.1 months). The overall local tumour progression rate was 13.3%. The overall survival at one year was 88.89% ( n = 63) and two years of 72.92% ( n = 48). The median survival time was 35 months (95% CI 30–42 months).

Conclusion

MWA provides an effective and feasible nonsurgical treatment option for solitary HCCs with reported local tumour progression, overall survival, and technical success consistent with internationally published literature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularMicrowavesTomography, X-Ray ComputedRadiography, InterventionalHumansRetrospective StudiesFemaleTreatment OutcomeMaleTertiary Care CentersAgedMiddle AgedAustraliaNeoplasm Recurrence, Local

Stichwörter der Autor:innen

computed tomographyhepatocellular carcinomamicrowave ablation

Autor:innen und Institutionen

  • Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia.
  • Queensland X-ray, Brisbane, Queensland, Australia.

ORCID-Profile: Andrew Whittering

Zitieren

APA

Whittering, A., & Halder, A. (2026). CT Guided Microwave Ablation for Hepatocellular Carcinomas: Outcomes From a Tertiary Australian Centre. Journal of Medical Imaging and Radiation Oncology. https://doi.org/10.1111/1754-9485.70070

Vancouver

Whittering A, Halder A. CT Guided Microwave Ablation for Hepatocellular Carcinomas: Outcomes From a Tertiary Australian Centre. Journal of Medical Imaging and Radiation Oncology. 2026. doi:10.1111/1754-9485.70070

BibTeX
@article{Whittering2026,
  author = {Whittering, Andrew and Halder, Arani},
  title = {CT Guided Microwave Ablation for Hepatocellular Carcinomas: Outcomes From a Tertiary Australian Centre},
  journal = {Journal of Medical Imaging and Radiation Oncology},
  year = {2026},
  doi = {10.1111/1754-9485.70070}
}
Kostenlos starten →